贝泰妮 (300957.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

43.1x

EV/EBITDA

16.1x

Market Cap

CNY 13.15B

MomentumView details →

1D Return

−1.99%

YTD Return

−15.15%

RSI (14)

55.0

ValuationView details →

P/E (Fwd)

43.1x

EV/EBITDA

16.1x

Market Cap

CNY 13.15B

RSI (14)

55.0

MomentumView details →

1D Return

−1.99%

YTD Return

−15.15%

ProfitabilityView details →

Gross Margin

73.72%

Net Margin

9.83%

EBITDA Margin

14.88%

ROE (TTM)

8.91%

ROA (TTM)

6.56%

Asset Turnover

0.66x

GrowthView details →

Revenue YoY

−1.07%

EPS YoY

+52.29%

FCF YoY

+794.71%

Revenue CAGR 3Y

+2.24%

EPS CAGR 3Y

−21.49%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.52

EPS Surprise

−17.22%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.18

Avg Surprise (4Q)

−17.22%

Rev Surprise

−7.10%

Capital & dividendView details →

Debt/Equity

0.14x

Current Ratio

3.63x

Quick Ratio

3.25x

Div Yield

1.93%

Div Rate

CNY 0.65

Div Growth 1Y

+8.33%

Financials snapshotView financials →

Revenue (TTM)

5.53B

Net Income (TTM)

543.34M

Op. CF (TTM)

1.09B

Next earningsOct 28, 2026 →

Latest newsMore news →

Yunnan Botanee Bio-Technology Group disclosed that as of August 31, 2026, it had repurchased 3.6997 million shares for about 120 million yuan under its buyback program.2d ago

Botanee announced a share buyback alongside its interim dividend.11d ago

Similar companies

德方纳米300769.SZ 金富科技003018.SZ 联化科技002250.SZ 盛弘股份300693.SZ 高特电子301669.SZ 焦作万方000612.SZ Find similar companies →

Latest newsMore news →

Yunnan Botanee Bio-Technology Group disclosed that as of August 31, 2026, it had repurchased 3.6997 million shares for about 120 million yuan under its buyback program.2d ago Botanee announced a share buyback alongside its interim dividend.11d ago Betaini (Yunnan Botanee Bio-Technology Group) announced its H1 2026 results: revenue of 2.592 billion yuan, up 9.27% year-on-year; net profit attributable to shareholders of 292 million yuan, up 18.30% from 247 million yuan in H1 2025; non-recurring-adjusted net profit of 246 million yuan, up 34.85%.11d ago